Eden Research (LON:EDEN) Shares Down 0.2% – Time to Sell?

Eden Research plc (LON:EDEN)’s stock price fell 0.2% during trading on Friday . The stock traded as low as GBX 3.59 ($0.05) and last traded at GBX 3.59 ($0.05). 10,000 shares were traded during mid-day trading, a decline of 99% from the average session volume of 920,772 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 0.2 %

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The stock has a market cap of £19.17 million, a PE ratio of -12.59 and a beta of 0.92. The firm has a fifty day moving average of GBX 3.88 and a 200 day moving average of GBX 3.95.

Insider Activity

In related news, insider Lykele van der Broek bought 256,000 shares of the stock in a transaction dated Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,975.16). Also, insider Alexander John Abrey bought 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,396.86). Company insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.